Transcatheter Aortic Valve Implantation and Four-Year Follow Up in a 99-Year-Old Patient
|
Alexander Jabs, Teoman Kilic, Nalan Schnelle, Felix Post, Markus Vosseler, Christian-Friedrich Vahl, Thomas Münzel, Ulrich Hink 2nd Department of Medicine, Cardiology/Angiology/Intensive Care, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Department of Cardiothoracic and Vascular Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany, Department of Cardiology, Kocaeli University Medical Faculty, Kocaeli, Turkey |
|
|
Transcatheter aortic valve implantation (TAVI) has emerged as a life-saving therapy in patients with severe aortic valve stenosis who are considered to be high-risk surgical candidates. However, there is a paucity of data on the long-term survival and quality-of-life in very old patients undergoing TAVI. Here, the case is reported of a now 104-year-old patient who underwent percutaneous transfemoral |
TAVI with a CoreValve™ prosthesis at the age of 99 years; details of his four-year outcome data are also provided. To best of the authors’ knowledge, this patient is the oldest reported to have undergone TAVI, and is currently living with good functional status more than four years after the intervention. |
| Transcatheter Aortic Valve Implantation and Four-Year Follow Up in a 99-Year-Old Patient | |
Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.
Purchase this Article
Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.
Website by CHP Design, London